• News
  • Business
  • Entertainment
  • Sports
  • Lifestyle
  • Technology
  • Elections

News

IndiaWorld

Sports

CricketIPLFootball

Business

Personal FinanceAutoMutual Funds

Entertainment

MoviesCelebrities NewsSouth CinemaOTTMovie Review

Education

JobsResults

Technology

GadgetsChatGPT

Cities

Delhi NCRCrime

Elections

Lifestyle

HealthTravel

Brand Wire

Religion and Spirituality

Astro

Trending

Offbeat

Fact Check

Explainers

Science

Education

HomeTopicCovishield
Continues below advertisement

Covishield

News
Entertainment
COVISHIELD Get Government's Nod As India's First COVID-19 Vaccine: Here's How Celebs Reacted
Health
Adar Poonawalla Exclusive: 'Covishield Vaccine Safe, It Is Not Bulletproof Hence Wearing Masks Important'
Health
India Gets 2 Vaccines Against Covid 19, Who Will Get Vaccinated First And How To Register? Check Details
India
India Corona Vaccine: PM Modi Hails DCGI's Vaccine Approval , Calls It 'A Road Towards Covid Free Nation'
India
Expert Panel Gives Nod To Bharat Biotech’s Covaxin For Restricted Emergency Use
Health
Race For Covid Vaccine Delivery Heats In India With Pfizer, And Serum Applied For Emergency Use Authorization
Health
Serum Institute Files Rs 100 Crore Case Against Volunteer Who Alleged Oxford Vaccine Made Him Ill; Know More
Health
Why AstraZeneca, Oxford 'Covishield' Vaccine A Better Fit Over Pfizer And Moderna Shots In India
Health
India May Get 100 Million Doses of Oxford’s Coronavirus Vaccine 'Covishield' By December
India
Covid-19 Vaccine Ready For Rollout By Dec, But Subject To Conditions: Serum Institute CEO Adar Poonawalla
Health
Serum Institute Denies Reports Claiming Indians To Get Covid-19 Vaccine Shots In 73 Days
Health
Covid 19: Serum Institute Of India Caps Oxford Vaccine 'Covishield' Ceiling Price At Rs 225/Dose
  • 13
  • 14
  • 15
  • 16
Continues below advertisement
Sponsored Links by Taboola
About UsFeedbackCareersAdvertise With UsSitemapDisclaimerPrivacy PolicyContact Us
FOLLOW US
This website follows the DNPA Code of Ethics. Copyright@2025. All rights reserved.